Literature DB >> 8515471

Crystals of human growth hormone-receptor complexes. Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent receptor dimerization.

M Ultsch1, A M de Vos.   

Abstract

A single-site human growth hormone mutant (hGH[G120R]), which inhibits receptor dimerization, was used to produce single crystals, suitable for high-resolution diffraction studies, of 1:1 complexes with the ligand-binding domain of the growth hormone receptor (hGHbp) and of the prolactin receptor (hPRLbp). Crystals of the hGH[G120R]-hGHbp complex are in space group P4(1)2(1)2 or P4(3)2(1)2 with a = 67.7 A, c = 228.0 A, and diffract to at least 2.2 A. Crystals of the complex between hGH[G120R] and hPRLbp are in space group P2(1)2(1)2 with a = 154.0 A, b = 68.4 A, c = 42.9 A, and diffract to at least 2.8 A. The structures of these two complexes will shed light on the early events in receptor activation, and provide the basis for an analysis of receptor specificity of growth hormone and prolactin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515471     DOI: 10.1006/jmbi.1993.1359

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

Review 1.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

2.  Differential in vivo activities of bovine growth hormone analogues.

Authors:  J Kopchick; X Z Chen; Y Li; R W Steger; J S Yun; T E Wagner; A Bartke
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

Review 3.  Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors.

Authors:  A A Kossiakoff; W Somers; M Ultsch; K Andow; Y A Muller; A M De Vos
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

4.  Growth hormone and aging.

Authors:  A Bartke; H Brown-Borg; B Kinney; J Mattison; C Wright; S Hauck; K Coschigano; J Kopchick
Journal:  J Am Aging Assoc       Date:  2000-10

Review 5.  Nanomedicines in the treatment of acromegaly: focus on pegvisomant.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes Romijn
Journal:  Int J Nanomedicine       Date:  2006

Review 6.  Growth hormone and aging.

Authors:  A Bartke
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.